Spherebio
1 known investors
SphereBio develops individualized cancer immunotherapies using engineered biological vesicles (OncoSpheres™) that capture a patient's own tumor antigens and deliver them into immune cells to train the immune system against cancer. The company combines biotechnology, synthetic virology, and AI to create individualized cancer vaccines manufactured without sequencing in under seven days.
Founders & leadership
JP
Julieta PortaCOO & Co-founder
GM
Guido MolinaCo-founder (Molecular Biologist)
MG
Martin GuerreroCo-founder (Physician & Bioinformatician)
Investors · 1
Frequently asked questions
- What does Spherebio do?
- SphereBio develops individualized cancer immunotherapies using engineered biological vesicles (OncoSpheres™) that capture a patient's own tumor antigens and deliver them into immune cells to train the immune system against cancer. The company combines biotechnology, synthetic virology, and AI to create individualized cancer vaccines manufactured without sequencing in under seven days.
- Who founded Spherebio?
- Spherebio was founded by Julieta Porta, Guido Molina, Martin Guerrero.
- Who are Spherebio's investors?
- Spherebio's investors include GRIDX.